Trials / Completed
CompletedNCT04440644
Italian Validation of the Beaumont Behavioural Inventory (BBI)
Validazione Italiana Dello Strumento BBI (Beaumont Behavioural Inventory) Per la Valutazione Delle Alterazioni Comportamentali Nel Paziente Affetto da Malattia Del Motoneurone
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 190 (actual)
- Sponsor
- Istituti Clinici Scientifici Maugeri SpA · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
Up to 50% of patients affected with amyotrophic lateral sclerosis (ALS) can show behavioral dysfunctions within the spectrum of frontotemporal degenerations (FTD) - namely, apathy, disinhibition, loss of sympathy/empathy, perseverative and stereotyped behaviours, dietary changes \[Strong et al., 2017\]. The Beaumont Behavioural Inventory (BBI) \[Elamin et al., 2017\] is a questionnaire designed for detecting FTD-spectrum behavioural changes in ALS patients. The present study aims at both validating the BBI in an Italian ALS population and determining normative cut-off values of the instrument.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | BBI | administration of psychometric test |
Timeline
- Start date
- 2019-09-17
- Primary completion
- 2020-09-30
- Completion
- 2020-11-30
- First posted
- 2020-06-19
- Last updated
- 2021-10-22
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04440644. Inclusion in this directory is not an endorsement.